Literature DB >> 2220803

Cystic fibrosis mutations in North American populations of French ancestry: analysis of Quebec French-Canadian and Louisiana Acadian families.

R Rozen1, R H Schwartz, B C Hilman, P Stanislovitis, G T Horn, K Klinger, J Daigneault, M De Braekeleer, B Kerem, L Tsui.   

Abstract

A 3-bp deletion (delta F508) in the cystic fibrosis (CF) gene is the mutation on the majority of CF chromosomes. We studied 112 CF families from North American populations of French ancestry: French-Canadian families referred from hospitals in three cities in Quebec and from the Saguenay-Lac St. Jean region of northeastern Quebec and Acadian families living in Louisiana. delta F508 was present on 71%, 55%, and 70% of the CF chromosomes from the major-urban Quebec, Saguenay-Lac St. Jean, and Louisiana Acadian families, respectively. A weighted estimate of the proportion of delta F508 in the French-Canadian patient population of Quebec was 70%. We found that 95% of the CF chromosomes with delta F508 had D7S23 haplotype B, the most frequent haplotype on CF chromosomes. In the Saguenay-Lac St. Jean families, 86% of the CF chromosomes without delta F508 had the B haplotype, compared with 31% for the major-urban Quebec and Louisiana Acadian families. The incidence of CF in the Saguenay-Lac St. Jean population was 1/895 live-born infants.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2220803      PMCID: PMC1683794     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  13 in total

1.  Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis.

Authors:  W K Lemna; G L Feldman; B Kerem; S D Fernbach; E P Zevkovich; W E O'Brien; J R Riordan; F S Collins; L C Tsui; A L Beaudet
Journal:  N Engl J Med       Date:  1990-02-01       Impact factor: 91.245

2.  Rapid nonradioactive detection of the major cystic fibrosis mutation.

Authors:  J Rommens; B S Kerem; W Greer; P Chang; L C Tsui; P Ray
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

3.  DNA amplification for detection of the XV-2c polymorphism linked to cystic fibrosis.

Authors:  C L Rosenbloom; B S Kerem; J M Rommens; L C Tsui; B Wainwright; R Williamson; W E O'Brien; A L Beaudet
Journal:  Nucleic Acids Res       Date:  1989-09-12       Impact factor: 16.971

4.  Regional mapping of six cloned DNA sequences on human chromosome 7.

Authors:  I Bartels; K H Grzeschik; D N Cooper; J Schmidtke
Journal:  Am J Hum Genet       Date:  1986-03       Impact factor: 11.025

5.  Prenatal diagnosis of cystic fibrosis by DNA amplification for detection of KM-19 polymorphism.

Authors:  G L Feldman; R Williamson; A L Beaudet; W E O'Brien
Journal:  Lancet       Date:  1988-07-09       Impact factor: 79.321

6.  Patterns of polymorphism and linkage disequilibrium for cystic fibrosis.

Authors:  X Estivill; P J Scambler; B J Wainwright; K Hawley; P Frederick; M Schwartz; M Baiget; J Kere; R Williamson; M Farrall
Journal:  Genomics       Date:  1987-11       Impact factor: 5.736

7.  Linkage of DNA markers to cystic fibrosis in 26 families.

Authors:  J E Spence; C L Rosenbloom; W E O'Brien; D K Seilheimer; S Cole; R E Ferrell; R C Stern; A L Beaudet
Journal:  Am J Hum Genet       Date:  1986-12       Impact factor: 11.025

8.  Further linkage data on cystic fibrosis: the Utah Study.

Authors:  R White; M Leppert; P O'Connell; Y Nakamura; S Woodward; M Hoff; J Herbst; M Dean; G Vande Woude; G M Lathrop
Journal:  Am J Hum Genet       Date:  1986-12       Impact factor: 11.025

9.  Cystic fibrosis mutations in the Hutterite Brethren.

Authors:  K Klinger; G T Horn; P Stanislovitis; R H Schwartz; T M Fujiwara; K Morgan
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

10.  A closely linked genetic marker for cystic fibrosis.

Authors:  R White; S Woodward; M Leppert; P O'Connell; M Hoff; J Herbst; J M Lalouel; M Dean; G Vande Woude
Journal:  Nature       Date:  1985 Nov 28-Dec 4       Impact factor: 49.962

View more
  6 in total

1.  Friedreich ataxia in Louisiana Acadians: demonstration of a founder effect by analysis of microsatellite-generated extended haplotypes.

Authors:  G Sirugo; B Keats; R Fujita; F Duclos; K Purohit; M Koenig; J L Mandel
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

2.  Attitudes toward genetic testing of Amish, Mennonite, and Hutterite families with cystic fibrosis.

Authors:  S R Miller; R H Schwartz
Journal:  Am J Public Health       Date:  1992-02       Impact factor: 9.308

3.  Variability of the genetic contribution of Quebec population founders associated to some deleterious genes.

Authors:  E Heyer; M Tremblay
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

4.  Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient.

Authors:  D Phaneuf; M Lambert; R Laframboise; G Mitchell; F Lettre; R M Tanguay
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

5.  Retrospective study of the cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in Guthrie cards from a large cohort of neonatal screening for cystic fibrosis.

Authors:  C Verlingue; B Mercier; I Lecoq; M P Audrézet; D Laroche; G Travert; C Férec
Journal:  Hum Genet       Date:  1994-04       Impact factor: 4.132

6.  Complete detection of mutations in cystic fibrosis patients of Native American origin.

Authors:  B Mercier; O Raguénès; X Estivill; N Morral; G C Kaplan; M McClure; T A Grebe; D Kessler; P F Pignatti; C Marigo
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.